The role of glycogen synthase kinase 3 (GSK-3) in activation p53 and the TREM2 signaling pathway

2017/27/N/NZ5/01079

Keywords

Descriptors

  • NZ3_1: Biologia komórki
  • NZ5_1: Etiologia chorób człowieka
  • NZ3_7: Przekaźnictwo sygnału

Panel

NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)

Host institution

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

Voivodeship: śląskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr Barbara Małgorzata Łasut-Szyszka

Number of co-investigators in the project: 2

Call

PRELUDIUM 14 – announced on 2017-09-15

Amount awarded
210 000 PLN
Project start date
2018-08-10
Project end date
2022-08-09
Project duration
48 months (the same as in the proposal)
Project status
Project settled

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (2)

  1. Synergistic activation of p53 by actinomycin D and nutlin-3a is associated with the upregulation of crucial regulators and effectors of innate immunity.

    Authors:
    Krześniak M, Zajkowicz A, Gdowicz-Kłosok A, Głowala-Kosińska M, Łasut-Szyszka B, Rusin M.
    Academic press:
    Cellular Signalling (year: 2020, volume: 69, pages: 109552), Publisher: Journal - Elsevier
    Status:
    Published
    DOI:
    10.1016/j.cellsig.2020.109552. – link to the publication
  2. Transcriptome Analysis of Cells Exposed to Actinomycin D and Nutlin-3a Reveals New Candidate p53-Target Genes and Indicates That CHIR-98014 Is an Important Inhibitor of p53 Activity

    Authors:
    Barbara Łasut-Szyszka, Beata Małachowska, Agnieszka Gdowicz-Kłosok, Małgorzata Krześniak, Magdalena Głowala-Kosińska, Artur Zajkowicz and Marek Rusin
    Academic press:
    International Journal of Molecular Sciences (year: 2021, volume: 22, 11072, pages: 46047), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/ijms222011072 – link to the publication

Articles in post-conference publications (12)

  1. How can p53 inhibit the Wnt signaling pathway?

    Authors:
    Barbara Łasut-Szyszka , Małgorzata Krześniak , Agnieszka Gdowicz-Kłosok , Artur Zajkowicz , Iwona Matuszczyk , Marek Rusin
    Conference:
    XXIV Gliwice Scientific Meetings (year: 2020, pages: 79), Publisher: Association for the Support of Cancer Research, Center of Oncology Maria Sklodowska-Curie Memorial Institute Branch in Gliwice, Silesian University of Technology
    Date:
    conference 20-21.11
    Status:
    Published
  2. The p53 tumor supressor protein stimulates the expression of BLNK -gene important in humoral immune system.

    Authors:
    Łasut-Szyszka B, Gdowicz-Kłosok A, Krześniak M, Zajkowicz A, Matuszczyk I, Rusin M.
    Conference:
    XXIInd Gliwice Scientific Meetings (year: 2018, pages: 72), Publisher: Association for the Support of Cancer Research, Center of Oncology Maria Sklodowska-Curie Memorial Institute Branch in Gliwice, Silesian University of Technology
    Date:
    conference 43420
    Status:
    Published
  3. Porównanie transktyptomów komórek A549 traktowanych interferonem-α1 lub czynnikami aktywującymi białko p53.

    Authors:
    Łasut-Szyszka B, Gdowicz-Kłosok A, Krześniak M, Zajkowicz A, Rusin M.
    Conference:
    IV Spotkania z Onkologią Molekularną i Translacyjną (year: 2019, pages: 24), Publisher: Centrum Onkologii - Instytut im. Marii Skłodowskiej - Curie
    Date:
    conference 43559
    Status:
    Published
  4. Nowe spojrzenie na białko p53 w kontekście metabolizmu komórki

    Authors:
    B. Łasut-Szyszka, A. Gdowicz-Kłosok, M. Krześniak, A. Będzińska, M. Rusin
    Conference:
    VIII Śląskie Spotkania Naukowe (year: 2021, pages: 46338), Publisher: Politechnika Śląska w Gliwicach, Narodowy Instytut Onkologii w Gliwicach, Stowarzyszenie na Rzecz Wspierania Badań nad Rakiem
    Date:
    conference 21,05
    Status:
    Published
  5. Inhibitor of glycogen synthase kinase 3 (CHIR-98014) increases pro-apoptotic potential of anticancer drugs

    Authors:
    Łasut-Szyszka B, Krześniak M, Głowala-Kosińska M, Gdowicz-Kłosok A, Matuszczyk I, Rusin M.
    Conference:
    XIIIrd Gliwice Scientific Meetings 2019 (year: 2019, pages: 85), Publisher: Association for the Support of Cancer Research, Center of Oncology Maria Sklodowska-Curie Memorial Institute Branch in Gliwice, Silesian University of Technology
    Date:
    conference 43791
    Status:
    Published
  6. Poszukiwanie nieznanych dróg p53 – analiza transkryptomu komórek A549 pod wpływem czynników aktywujących białko p53 oraz inhibitora kinaz syntazy glikogenu.

    Authors:
    Łasut-Szyszka B, Gdowicz-Kłosok A, Krześniak M, Zajkowicz A, Rusin M.
    Conference:
    IV Studencka Konferencja Biologii Medycznej Biofuzje (year: 2019, pages: 95), Publisher: Uniwersytet Warszawski, Wydział Biologii
    Date:
    conference 43609
    Status:
    Published
  7. What does an inhibitor of glycogen synthase kinase-3 really inhibit?

    Authors:
    Barbara Łasut-Szyszka, Agnieszka Gdowicz-Kłosok, Małgorzata Krześniak, , Iwona Matuszczyk and Marek Rusin
    Conference:
    The 5th Warsaw Conference on Perspectives of Molecular Oncology: Molecular Immunology of Cancer (year: 2020, pages: 37), Publisher: Maria Sklodowska-Curie National Research Institute of Oncology Roentgena 5 Str. Warsaw, Poland
    Date:
    conference 23-24.09
    Status:
    Published
  8. Does p53 mediate the upregulation of selected genes induced by cell treatment with actinomycin D and nutlin-3a?

    Authors:
    Barbara Łasut-Szyszka, Małgorzata Krześniak, Agnieszka Gdowicz, Artur Zajkowicz, Iwona Matuszczyk and Marek Rusin
    Conference:
    4th International Wroclaw Scientific Meetings (year: 2020, pages: 167-168), Publisher: Wroclaw Medical University
    Date:
    conference 09-10.10
    Status:
    Published
  9. In search of an unknown mechanism of cancer… - effect of the glycogen synthase kinase 3 inhibitor on the p53 pathways.

    Authors:
    Łasut-Szyszka B, Krześniak M, Gdowicz-Kłosok A, Rusin M.
    Conference:
    EMBO Young Scientists Forum 2019 (EYSF) (year: 2019, pages: 92), Publisher: EMBO
    Date:
    conference 43643
    Status:
    Published
  10. The experimental Alheimer's disease drug regulates p53 in cancer cells.

    Authors:
    Łasut-Szyszka B, Krześniak M, Gdowicz-Kłosok A, Rusin M.
    Conference:
    4 th Polish Scientific Networks (year: 2019, pages: 136), Publisher: AMU, FNP
    Date:
    conference 43727
    Status:
    Published
    DOI:
    link to the publication
  11. Identification of new genes regulated by the anticancer p53 protein

    Authors:
    B.Łasut-Szyszka, B.Małachowska, M. Pietrowska, M. Gawin, M. Krześniak, A. Gdowicz-Kłosok, A.Bezdzinska1, M. Rusin
    Conference:
    The Biochemistry Global Summit – the 25th IUBMB, 46th FEBS and 15th PABMB Congresses (year: 2022, pages: 208), Publisher: FEBS Open Bio
    Date:
    conference 9-14.07
    Status:
    Published
  12. How can we explain the activation of TREM2 associated with microglia diseases in cancer cells? – CHIR 98014 inhibits the activation of a subset of p53-regulated genes

    Authors:
    B. Łasut-Szyszka, B. Małachowska, M. Krześniak, A. Gdowicz-Kłosok, A. Będzińska, M. Rusin
    Conference:
    The 45th FEBS Congress (year: 2021, pages: 239), Publisher: FEBS Open Bio
    Date:
    conference 03-08.07
    Status:
    Published

« New search

Graphic design and implementation: Jakub Piotrowski